Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for Juvenile Primary Fibromyalgia Syndrome
NCT00115804Phase 3Completed
- Sponsor
- University of Cincinnati
- Start
- Jun 2005
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluoxetine in Juvenile Fibromyalgia Syndrome (JFMS), sponsored by University of Cincinnati. Started Jun 2005; status: completed.
02
Drugs
fluoxetine
03
Conditions
Juvenile Fibromyalgia Syndrome (JFMS)
Beyond the preview
Go deeper on NCT00115804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115804.